Feb 12, 2020 - Sports

The average NBA team is now worth $2.1 billion

Expand chart
Reproduced from Forbes; Chart: Axios Visuals

The average NBA franchise is now valued at $2.12 billion, per Forbes — a figure that has grown 476% in the past decade.

Why it matters: Thanks to the NBA's international growth and the $24 billion TV deal it signed with ESPN and Turner in 2014, team values have grown at a much faster rate than the other three major U.S. sports leagues.

  • NBA: 476% growth
  • MLB: 262% growth
  • NHL: 192% growth
  • NFL: 179% growth

Most valuable teams: The Knicks ($4.6 billion) grabbed the top spot for the fifth straight year, followed by the Lakers ($4.4 billion) and Warriors ($4.3 billion). Among all American sports, only the Cowboys ($5.5 billion) and Yankees ($4.6 billion) can rival them.

  • Filling out the top 10: Bulls ($3.2 billion), Celtics ($3.1 billion), Clippers ($2.6 billion), Nets ($2.5 billion), Rockets ($2.48 billion), Mavericks ($2.4 billion) and Raptors ($2.1 billion).
  • The bottom five: Only five teams are valued at less than $1.5 billion: Pistons ($1.45 billion), Magic ($1.43 billion), Timberwolves ($1.38 billion), Pelicans ($1.4 billion) and Grizzlies ($1.3 billion).

Wild stat: In 1999, the Warriors were the seventh-least valuable NBA franchise and the Clippers ranked dead last. Two decades later, they are now the third- and sixth-most valuable NBA franchises, respectively.

Go deeper: The NBA's engagement problem

Go deeper

Schumer wants $8.5 billion for coronavirus preparation

Photo: Chip Somodevilla/Getty Images

Senate Minority Leader Chuck Schumer (D-N.Y.) on Wednesday proposed $8.5 billion to help combat the coronavirus. The Trump administration has asked for $2.5 billion this year, some of which would repurpose existing funds.

Between the lines: Schumer's office noted that Congress approved $7 billion during the 2009 H1N1 flu outbreak, a public-health emergency with many similarities to the coronavirus scare.

Trump signs $8 billion emergency coronavirus funding package

Photo: Jabin Botsford/The Washington Post via Getty Images

President Trump signed Friday a bipartisan $8 billion deal to provide emergency funding to combat the coronavirus outbreak.

The big picture: The Senate passed the bill 96-1 on Thursday, after it flew through the House 415-2 on Wednesday afternoon — marking a rare moment of congressional unity in the face of a public health crisis.

Go deeperArrowUpdated Mar 6, 2020 - Politics & Policy

Big Pharma is on a stock buyback spree

Data: Company filings; Chart: Axios Visuals

In 2018, the year the Republican tax law went into full effect, 12 of the largest pharmaceutical companies spent more money buying back their stock than they spent on drug research and development.

The big picture: When billions of dollars became available to the biggest drug companies, their main priority was to juice earnings, along with the paydays of their executives and investors — not investments in new treatments or relief for patients who can't afford their drugs.

Go deeperArrowMar 5, 2020 - Health